 |
 |
 |
 |
 |
 |
 |
||||
|
||||||||||
 Construction, Characterization and PathologyPolypeptide Growth Factors and Prostate CancerAndrogen Axis and Prostate CancerImmunotherapyPre-Clinical TrialsReviews |
1. Greenberg, N.M., DeMayo, F.J. , Sheppard, P.C., Barrios, R.,Lebovitz, R.,Finegold, M., Angelopoulou, R., Dodd, J.G., Duckworth, M.L., Rosen, J.M. and Matusik, R.J. 1994. The rat probasin gene promoter directs hormonally- and developmentally-regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol. 8:230-239. [PubMed] 2. Greenberg, N.M., DeMayo, F.J., Finegold, M., Medina, D., Tilley, W., J.O. Aspinall, Cunha, G.R., Donjacour, A.A., Matusik, R.J., and Rosen, J.M. 1995. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. (USA) 92:3439-3443. [PDF] 3. Gingrich, J.R. and Greenberg, N.M. A transgenic mouse prostate cancer model. 1996. Toxicologic Pathology 24: 502-504. 8. [PubMed] 4. Gingrich, J.R., Barrios, R.J., Morton, R.A., Boyce, B.F., DeMayo, F.J., Finegold, M.J., Angelopoulou, R., Rosen, J.M., and Greenberg, N.M. 1996. Metastasic prostate cancer in a transgenic mouse. Cancer Research 56: 4096-4102.[PubMed] [PDF] 5. Greenberg, N.M. Transgenic models for prostate cancer research. 1996. Urologic Oncology 2: 119-122. 6. Hsu, C.X., Ross, B.D., Chrisp, C.E., Derrow, S.Z., Charles, L.G., Pienta, K.J., Zheng, Z., Greenberg, N.M. and Sanda, M.G. 1998. Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J. Urology 160(4):1500-1505 [PubMed] 7. Gingrich, J., Barrios, R.J. Foster, B.A. and Greenberg, N.M. 1999. Pathologic Progression of Autochthonous Prostate Cancer in the TRAMP. . Prostate Cancer and Prostatic Diseases 2:70-75 [PDF] 8. Pu, Y-S., Luo, W., Lu, H-H., Greenberg, N.M. and Lin, S-H. 1999. Differential Expression of C-CAM Cell Adhesion Molecule in Prostate Carcinogenesis in a Transgenic Mouse Model. J. Urology 162:892-896 9. Schatten, H., Allison M.D., Wiedemeiera, A.M., Taylor M., Lubahn, D.B., Greenberg, N.M., Besch-Williford, C., Rosenfeld, C.S., Day, J.K. and , M. 2000. Centrosome - centriole abnormalities are markers for abnormal cell divisions and cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model. Biol Cell 92:331-340. [PDF] 10. Bruckheimer, EM, Brisbay, S., Johnson, DJ., Gingrich, JR., Greenberg, N., and McDonnell, T.J. 2000. Bcl-2 accelerates multistep prostate carcinogenesis in vivo. Oncogene 19:5251-5258. [PDF] 11. Kwabi-Addo, B, Giri, D., Schmidt, K., Podsypanina, K., Parsons, R., Greenberg, N. and Ittmann, M. 2001. Haploinsufficiency of the PTEN tumor suppressor gene promotes tumor progression. Proc. Natl. Acad. Sci, USA 98(20):11563-11568. [PDF] 12. Leman, E.S., Arlotti, J.A., Dahir, R. Greenberg, N. and Getzenberg, R.H. 2002. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer. Journal of Cellular Biochemistry 86:203?212. [PDF] 13. Uzgare, A.R., Kaplan, P.J. and Greenberg, N.M. 2003. Differential Expression and Activation of p38 and Erk MAP Kinase during Initiation and Progression of Prostate Cancer. The Prostate 55:128-139. [PDF] 14. Kaplan-Lefko, P.J., Chen, M-T., Ittmann, M.M., Barrios, R.J., Ayala, G.E., Huss, W.J., Maddison, L.A., Foster, B.A. and Greenberg, N.M. 2003. Pathobiology of Autochthonous Prostate Cancer in a Pre-Clinical Transgenic Mouse Model. The Prostate 55:219-237. [Article PDF] [HiRes Graphics PDF] 15. Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model. Prostate Cancer and Prostatic Disease 6(3): 204 –211, 2003 [PDF] 16. Maddison, L.A. and Greenberg, NM. 2003. Differential expression of cell cycle regulatory molecules and evidence for a “cyclin switch” during progression of prostate cancer. The Prostate (in press; e-published Nov 20, 2003) [PDF] |
